ADVENTRX Pharma Inc. (ANX) announced the completion of the sale of shares of its 5% Series B convertible preferred stock pursuant to a registered direct offering to a single institutional investor, representing gross proceeds of approximately $1.36 million. The company noted that 25%, or approximately $340,250, of the gross proceeds will be placed in an escrow account, which will be released to make the dividend and other payments.
{loadposition link_supportresistance}
{loadposition homeaccordion2}
{loadposition contentad}
The preferred stock is convertible into company shares at the option of the investor at $0.1432 per share and will accrue a 5% dividend until July 6, 2014. If the convertible preferred stock is converted at any time prior to July 6, 2014, the company will pay the holder an amount equal to the total dividend that would accrue on the convertible preferred stock from the conversion date through July 6, 2014, or $250 per $1 thousand principal amount of convertible preferred shares converted, less any dividend payments made with respect to such converted convertible preferred shares.
ADVENTRX Pharma Inc. (ANX) announced that it has obtained a commitment to purchase shares of its 5% Series B convertible preferred stock pursuant to a registered direct offering to a single institutional investor, representing gross proceeds of approximately $1.36 million.
{loadposition link_supportresistance}
{loadposition homeaccordion2}
{loadposition contentad}
The company noted that, 25% or approximately $340,250 of the gross proceeds will be placed in an escrow account, which amounts will be released to make the dividend and other payments. The company expects the offering to close on or before July 3.
The preferred stock is convertible into company shares at the option of the investor at $0.1432 per share and will accrue a 5% dividend until July 6, 2014.
If the convertible preferred stock is converted at any time prior to July 6, 2014, the company will pay the holder an amount equal to the total dividend that would accrue on the convertible preferred stock from the conversion date through July 6, 2014, or $250 per $1 thousand principal amount of notes converted less any dividend payments made with respect to the converted convertible preferred stock.
Western Refining WNR BMO Capital Markets Underperform » Market Perform Merix MERX Jefferies & Co Underperform » Hold ADVENTRX Pharma ANX Dawson James Sell » Speculative Buy Nextest Systems NEXT Needham & Co Hold » Buy MRV Comms MRVC Needham & Co Hold » Buy MKS Instruments MKSI Banc of America Sec Sell » Neutral Conexant CNXT Roth Capital Sell » Hold UBS AG UBS JP Morgan Underweight » Neutral Forest Labs FRX Citigroup Sell » Hold The Medicines Co MDCO UBS Sell » Buy Navteq NVT Deutsche Securities Sell » Hold PDL BioPharma PDLI Wachovia Mkt Perform » Outperform ProLogis PLD Banc of America Sec Neutral » Buy AMB Property AMB Banc of America Sec Neutral » Buy
DOWNGRADES
Prospect Energy PSEC Ferris Baker Watts Neutral » Sell Alon USA Energy ALJ BMO Capital Markets Outperform » Market Perform ADVENTRX Pharma ANX Fortis Bank Buy » Hold Navteq NVT JMP Securities Mkt Outperform » Mkt Perform Navteq NVT AmTech Research Buy » Neutral Onyx Pharma ONXX Bear Stearns Outperform » Peer Perform Mobile TeleSystems MBT Bear Stearns Outperform » Peer Perform Citigroup C Punk, Ziegel & Co Mkt Perform » Sell FLIR Systems FLIR Needham & Co Buy » Hold Wrigley WWY Stifel Nicolaus Buy » Hold Axcan Pharma AXCA CIBC Wrld Mkts Sector Outperform » Sector Perform Smith Intl SII Calyon Securities Add » Neutral Natl Oilwell Varco NOV Calyon Securities Buy » Add XL Capital XL Wachovia Outperform » Mkt Perform ACE Limited ACE Wachovia Outperform » Mkt Perform Everest Re RE Wachovia Outperform » Mkt Perform IDM Pharma IDMI Cantor Fitzgerald Buy » Hold Biogen Idec BIIB Credit Suisse Neutral » Underperform Navteq NVT UBS Buy » Neutral CBS Corp CBS Deutsche Securities Buy » Hold Syntax-Brillian BRLC Robert W. Baird Outperform » Neutral
Technical analysis video of individual stock trading ideas for Tuesday June 12, 2007 including; American Superconductor Corporation (Public,
NASDAQ:AMSC), ADVENTRX Pharmaceuticals, Inc. (Public,
AMEX:ANX), AsiaInfo Holdings, Inc. (Public,
NASDAQ:ASIA), TranSwitch Corporation (Public,
NASDAQ:TXCC) and Electronic Arts Inc. (Public,
NASDAQ:ERTS). Trend analysis for daytraders and swingtraders of stocks and options. Trading stocks involves risk; this information should not be viewed as trading recommendations.
The video is available atYOUTUBEbecause I can participate in revenues from advertising on their site, if I embed the videos here I will not get paid.While there, register and rank my video so it will be seen by a wider audience, thanks!